Treating the Opiate Epidemic

Treating the Opiate Epidemic 

The webinar will cover buprenorphine and its clinical use in much more detail including short and long term outcomes. It will also cover psychosocial interventions to be used with these medications and emphasize the need for more buprenorphine prescribers.

$19.95

Hours: 1.00
REL-HHS-0-W006

Certificates

Certificates provided by accrediting body (3 Match)

Illinois Alcohol and Drug Abuse Professional Certification Association

1.0 HOURS


Categories Counselor I or II, Preventionist I or II, CARS I or II, MISA I or II, PCGC II, CCJP II, CAAP I, CRSS II, CPRS I or II, MAATP I or II, NCRS II, CFPP II, CVSS II
This activity is approved for 1.00 contact hours.

California Association of Alcohol and Drug Educators

1.0 HOURS


Relias Learning is an approved provider of Continuing Education. Provider number: CP40 910 H 0318 for 1.00 CEHs.

Oklahoma Board of Licensed Alcohol and Drug Counselors

1.0 HOURS


Course Details

Course Code: REL-HHS-0-W006
Hours: 1
Type: Online Course
Content Expiration Date: 1/31/2020
Learning Objectives:
Identify and diagnose opiate use disorder by recognizing the high prevalence and incidence in the current epidemic
Recognize the new use of opiate antagonists, such as naloxone, by non-medical persons to prevent opiate overdose deaths
Describe treatment methods for opiate use disorders including innovative detoxification and maintenance agents such as buprenorphine and depot naltrexone.
Recognize the key roles of behavioral therapies, self-help programs, physical exercise, supported employment, and other nonpharmacologic interventions for primary and secondary prevention
Instructor: Thomas Kosten, MD
Dr. Kosten is the JH Waggoner Chair and Professor of Psychiatry, Pharmacology, Immunology and Neuroscience, vice-Chair for Psychiatry and Co-director of the Dan L. Duncan Institute for Clinical and Translational Research (ICTR) at Baylor College of Medicine. He is the founding Vice Chair for Addiction Psychiatry of the American Board of Psychiatry and Neurology, and Past President of both the American Academy of Addiction Psychiatry (AAAP) and the College on Problems of Drug Dependence (CPDD). He is a Distinguished Life Fellow in the American Psychiatric Association (APA) and a Fellow of the American College of Neuropsychopharmacology (ACNP). He has served as a Congressional Fellow in the US House of Representatives and has been a long-standing member of various substance abuse commissions for the National Academy of Sciences (NAS) as well as various advisory boards for the Food and Drug Administration (FDA) and the Department of Defense (DOD). He is the current Editor for the American Journal on Addictions, past Editor for the American Journal of Drug and Alcohol Abuse, and serves on the board of several notable journals in substance abuse. He has published over 700 papers, books, and reviews describing his contributions, particularly in the use of pharmacotherapeutics for treating cocaine and opioid addictive disorders as well as his work in vaccine development for cocaine and methamphetamine addictions. Disclosure: Thomas Kosten, MD discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Alkermes as Grant/Research Support
Target Audience:
The target audience for this course is: entry and intermediate level Alcohol and Drug Counselors; entry and intermediate level Physicians; entry level Psychologists; intermediate and advanced level Nurses; in the following settings: Health and Human Services.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.